Viracta Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 176-200 of 861 matching filings.

Per page
25
Current page
8
4

FORM 4 SUBMISSION

Filing date
29 Sep 2021
Reporting date
28 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Aug 2021
Reporting date
16 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Aug 2021
Reporting date
16 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Aug 2021
Reporting date
14 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Aug 2021
Reporting date
14 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
12 Aug 2021
Reporting date
12 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
21 Jul 2021
Reporting date
21 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
06 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-256647

EFFECT filing

Filing date
04 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
02 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2021
Reporting date
28 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
28 May 2021
Reporting date
27 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-256647

S-3

Filing date
28 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
12 May 2021
Reporting date
12 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
14 Apr 2021
Reporting date
14 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-255002

S-8

Filing date
02 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
01 Apr 2021
Reporting date
26 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Mar 2021
Reporting date
26 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .